Substituted piperidines--highly potent renin inhibitors due to induced fit adaptation of the active site.
暂无分享,去创建一个
C. Oefner | A. Binggeli | H. Märki | V. Breu | W. Wostl | H P Märki | A Binggeli | V Breu | D Bur | W Fischli | R Güller | G Hirth | M Müller | M Scalone | H Stadler | E Vieira | M Wilhelm | W Wostl | D. Bur | C Oefner | W. Fischli | R. Güller | G. Hirth | H. Stadler | E. Vieira | M. Wilhelm | M. Müller | M. Scalone
[1] N. Hollenberg,et al. Renal circulation and blockade of the renin-angiotensin system. Is angiotensin-converting enzyme inhibition the last word? , 1995, Hypertension.
[2] J. Ménard,et al. Effects of Blocking the Angiotensin II Receptor, Converting Enzyme, and Renin Activity on the Renal Hemodynamics of Normotensive Guinea Pigs , 1993, Journal of cardiovascular pharmacology.
[3] D. Michelot. Highly Stereoselective Synthesis of Acetates of Mono- and Diunsaturated Alcohols and Analogous Aldehydes, Components of Lepidopteran Sex Pheromones, using Tetrakis[triphenylphosphine]-palladium , 1983 .
[4] N. Markandu,et al. Maintenance of blood pressure by the renin–angiotensin system in normal man , 1981, Nature.
[5] M. Weber,et al. Clinical experience with the angiotensin II receptor antagonist losartan. A preliminary report. , 1992, American journal of hypertension.
[6] F. Bigi,et al. Modification of the nickl reaction : A general synthetic approach to 2-vinyl-2,3-dihydrobenzofurans , 1983 .
[7] D. Dezeeuw,et al. RENAL AND SYSTEMIC EFFECTS OF THE RENIN INHIBITOR REMIKIREN IN PATIENTS WITH ESSENTIAL-HYPERTENSION , 1995 .
[8] A. Mann,et al. Selective Removal of the Tert-Butoxycarbonyl Group from Secondary Amines: ZnBr2 as the Deprotecting Reagent , 1989 .
[9] W. Kiowski,et al. Functional and biochemical analysis of angiotensin II-forming pathways in the human heart. , 1997, Circulation research.
[10] G. Chatellier,et al. Blood pressure effects of acute intravenous renin or oral angiotensin converting enzyme inhibition in essential hypertension , 1994, Journal of hypertension.
[11] B. Healy,et al. Angiotensin II-forming pathways in normal and failing human hearts. , 1990, Circulation research.
[12] S. Mahboobi,et al. Synthesis of Esters of 3‐(2‐Aminoethyl)‐1H‐indole‐2‐acetic Acid and 3‐(2‐aminoethyl)‐1H‐indole‐2‐malonic acid (= 2‐[3‐(2‐aminoethyl)‐1H‐indol‐2‐yl]propanedioic acid) 4th communication on indoles, indolenines, and indolines , 1988 .
[13] R. Gentz,et al. Recombinant human renin produced in different expression systems: biochemical properties and 3D structure. , 1996, Protein expression and purification.
[14] R. Luther,et al. Immediate blood pressure effects of the renin inhibitor enalkiren and the angiotensin-converting enzyme inhibitor enalaprilat. , 1991, American heart journal.
[15] N. Schork,et al. Mixture Analysis of Erythrocyte Lithium‐Sodium Countertransport and Blood Pressure , 1989, Hypertension.
[16] D. Hutchinson,et al. The Synthesis of 1,1-Cyclopropanediylbis(phosphonic acid) , 1990 .